Need a specific person's email?
Browse ISA Pharmaceuticals's employee directory (about 5 employees) and reveal verified emails free.
ISA Pharmaceuticals's most common email format is First.Last@isa-pharma.com (ex. John.Doe@isa-pharma.com), used for 50% of isa-pharma.com addresses. ISA Pharmaceuticals uses 4 email patterns.
| Format | Example | Share of isa-pharma.com |
|---|---|---|
| First.Last@isa-pharma.comMost common | John.Doe@isa-pharma.com | |
| Last@isa-pharma.com | Doe@isa-pharma.com | |
| FLast@isa-pharma.com | JDoe@isa-pharma.com | |
| First@isa-pharma.com | John@isa-pharma.com |
Browse ISA Pharmaceuticals's employee directory (about 5 employees) and reveal verified emails free.
Biotechnology ResearchSouth Holland, Netherlands2-10 Employees
ISA Pharmaceuticals B.V. is a biotechnology company focused on immunotherapies for cancer and persistent viral infections. It develops fully synthetic immunotherapies using its Synthetic Long Peptide (SLP) platform and AMPLIVANT technology to mobilize the body's immune defenses against disease. Its lead program, ISA101, targets HPV16-induced cancers and is in clinical development for advanced cervical cancer, HPV16-positive tumors, and anal intraepithelial neoplasia, with prior proof of concept in vulvar intraepithelial neoplasia. The company has partnered with Regeneron to explore combining ISA101 with a PD-1 inhibitor. Founded in 2004, ISA is based in Leiden, South Holland. A recent development includes the initiation of the HEB-PEP study in 2023, signaling continued progress in its clinical program.
Most common format
First.Last@isa-pharma.com
Example: John.Doe@isa-pharma.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.